The administration of dexmedetomidine was associated with reduced perioperative requirements for opioids in pediatric tonsillectomy, along with lower likelihoods of emergence delirium and ...

A recent systematic review published in the Delhi Journal of Ophthalmology in June 2026 highlights an exciting advancement in ...

An investigational, orally dissolving film formulation of dexmedetomidine (BXCL501, BioXcel Therapeutics) can rapidly relieve mild to moderate acute agitation in patients with bipolar disorder (BD), ...

For women with prenatal depression undergoing cesarean delivery, dexmedetomidine reduces the incidence of positive postpartum depression (PPD) screening, according to a study published online Jan. 25 ...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Dexmedetomidine Injection, USP in ...

Researchers have discovered a promising approach for reducing brain injury risk in patients undergoing carotid artery stenting (CAS). CAS is a procedure commonly performed in elderly patients with ...

Learn everything you need to know about Dexmedetomidine-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, ...

Please provide your email address to receive an email when new articles are posted on . At 7 and 42 days postpartum, women who received dexmedetomidine had lower positive postpartum depression rates.

BXCL501 is an oral thin film formulation of dexmedetomidine, a selective alpha-2a receptor agonist. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to BXCL501 ...

Details concerning the Dexmedetomidine medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, and ...